Spring Bank Pharmaceuticals, Inc. (38) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Side Letter, dated June 30, 2021, to (a) the License and Collaboration Agreement, dated August 24, 2016, by and among BBB Holding Ltd (f/k/a F-star Gamma Limited, DBH ), F-star...
(Filed With SEC on August 13, 2021)
-
Form of Warrant issued under the Venture Loan and Security Agreement, dated April 1, 2021
(Filed With SEC on May 17, 2021)
-
Underwriting Agreement, dated May 6, 2021, between F-star Therapeutics, Inc. and SVB Leerink LLC
(Filed With SEC on May 10, 2021)
-
STING Agonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare Inc.,...
(Filed With SEC on November 20, 2020)
-
Form of Restricted Stock Unit Agreement
(Filed With SEC on May 7, 2020)
-
Form of Amended and Restated Warrant
(Filed With SEC on April 13, 2020)
-
Venture Loan and Security Agreement, dated April 1, 2021, by and among F-star Therapeutics, Inc., as borrower, F-star Therapeutics Limited, as guarantor, and Horizon Technology...
(Filed With SEC on May 17, 2021)
-
STING Antagonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare...
(Filed With SEC on November 20, 2020)
-
Loan and Security Agreement, dated September 3, 2019
(Filed With SEC on September 4, 2019)